New Japanese Drug Pemafibrate Improves Lipid Profiles in Diabetes New Japanese Drug Pemafibrate Improves Lipid Profiles in Diabetes

Patients with type 2 diabetes and hypertriglyceridemia had improvements in lipid profiles and insulin resistance with pemafibrate, according to a Japanese trial that showed the drug is also well tolerated.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news